Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,331,353
-$287,752 QoQ
Shares Held
96,817
+3.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#889
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chicago Partners Investment Group LLC holds $61,906,541 across 11 Drug Manufacturers - General names. PFE ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,216 | $21,848,818 | |
| 2 | ABBV |
AbbVie Inc.
|
59,244 | $14,908,160 | |
| 3 | JNJ |
Johnson & Johnson
|
30,694 | $7,795,355 | |
| 4 | MRK |
Merck & Co., Inc.
|
39,284 | $5,047,994 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
60,440 | $3,482,552 | |
| 6 | AMGN |
Amgen Inc
|
6,922 | $2,506,594 | |
| 7 | PFE |
Pfizer Inc
This page
|
96,817 | $2,331,353 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,079 | $1,273,380 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,331,353 | 96,817 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,619,105 | 93,273 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,048,199 | 82,257 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,204,453 | 86,517 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,880,296 | 77,570 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,852,556 | 73,108 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,157,631 | 81,328 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,404,103 | 83,072 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,272,983 | 81,236 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,075,700 | 74,800 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,172,608 | 75,464 | Shares | Sole | 2024-02-23 | |
| 2023-09-30 | $2,542,447 | 76,649 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,869,843 | 78,240 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,823,849 | 69,212 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $3,272,596 | 63,868 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,644,022 | 60,421 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,748,537 | 52,423 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,662,893 | 51,437 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $3,025,013 | 51,228 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,225,423 | 51,742 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,077,163 | 53,043 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,945,297 | 53,693 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,899,469 | 51,602 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,722,549 | 46,936 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,509,924 | 46,175 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,437,790 | 44,050 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||